|
市場調査レポート
商品コード
1395748
機械式人工呼吸器の世界市場規模、シェア、産業動向分析レポート:モード別、コンポーネント別、製品タイプ別、年齢層別、エンドユーザー別、地域別展望と予測、2023年~2030年Global Mechanical Ventilators Market Size, Share & Industry Trends Analysis Report By Mode, By Component, By Product Type, By Age Group (Adult, Geriatric, and Pediatric & Neonatal), By End User, By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
機械式人工呼吸器の世界市場規模、シェア、産業動向分析レポート:モード別、コンポーネント別、製品タイプ別、年齢層別、エンドユーザー別、地域別展望と予測、2023年~2030年 |
出版日: 2023年11月30日
発行: KBV Research
ページ情報: 英文 485 Pages
納期: 即納可能
![]() |
機械式人工呼吸器市場規模は、予測期間中にCAGR 12.6%で成長し、2030年には167億米ドルに達すると予測されます。2022年の市場規模は103万9,400台、成長率は27.4%となっています(2019-2022年)。
KBV Cardinalのマトリックスに示された分析によると、Medtronic PLCが市場の先駆者です。例えば、2022年4月、Medtronic PLCはGEヘルスケアと協業し、外来手術センター(ASCs)とオフィスベースのラボ(OBLs)におけるケアのユニークなニーズと需要に焦点を当てた。この提携により、顧客は広範な製品ポートフォリオ、財務ソリューション、卓越したサービスを利用できます。ゼネラル・エレクトリック(GE)社、Koninklijke Philips N.V.、Dragerwerk AG &Co.KGaAといった企業が、市場における主要なイノベーターです。
COVID-19の影響分析
COVID-19が市場に与えた最も直接的で目に見える影響は、これらの救命機器に対する需要がかつてないほど急増したことです。ウイルスが急速に蔓延し、各国のヘルスケア・システムを圧倒したため、重症患者をサポートする人工呼吸器が大幅に不足しました。病院やヘルスケア施設は、COVID-19患者の流入に対応するために人工呼吸器の能力を増強する必要性に迫られました。COVID-19は、遠隔医療ネットワークへの人工呼吸器の統合など、遠隔モニタリングと遠隔医療ソリューションの採用を加速させました。これらの設計は、従来の人工呼吸器の高度な機能の一部を欠いていたとしても、需要の急増に対応するために必要不可欠な機能に重点を置いたものでした。このような技術革新は短期的な救済をもたらしたが、同時に急速に開発された機器の品質と安全性についての懸念も引き起こしました。したがって、COVID-19パンデミックは市場にプラスの効果をもたらしました。
市場成長要因
呼吸器疾患の有病率の上昇
COPD、喘息、間質性肺疾患などの呼吸器系疾患は、特に高齢化した人口集団において高い頻度で蔓延しています。これらの疾患では、長期的または断続的な人工呼吸サポートが必要となることが多く、機械式人工呼吸器に対する持続的な需要が生じています。心不全や神経筋障害などのさまざまな慢性疾患は呼吸合併症を引き起こすことがあり、患者の最適なケアのために機械的人工呼吸が必要となります。これらの疾患の併発が人工呼吸器の需要を高めています。呼吸窮迫症候群や気管支炎などの小児・新生児呼吸器疾患の流行は、新生児・小児用特殊人工呼吸器を必要とします。呼吸器疾患の蔓延が、機械式人工呼吸器と遠隔医療ネットワークおよび遠隔モニタリング技術の統合を促進しています。これにより、ヘルスケアプロバイダーは呼吸器疾患の患者を遠隔監視し、人工呼吸器の設定を調整できるようになり、ケアへのアクセスが改善されます。呼吸器疾患の有病率の上昇は市場成長の重要な要因です。
在宅換気プログラムの拡大
在宅換気プログラムにより、在宅環境における機械式人工呼吸器の需要が拡大しています。これらの人工呼吸器はコンパクトで使いやすく、操作が簡単であることが多いため、患者や介護者に適しています。COPD、神経筋障害、肥満性低換気症候群などの慢性呼吸器疾患の患者は、長期の人工呼吸サポートが必要になることがあります。在宅換気プログラムはこれらの患者に解決策を提供し、換気装置の使用を延長します。在宅人工呼吸器は患者の快適性を重視して設計されています。在宅人工呼吸プログラムには遠隔医療が組み込まれることが多く、患者は遠隔から専門医の診察にアクセスすることができます。これは遠隔地や十分なサービスを受けていない地域の患者にとって特に重要です。在宅人工呼吸プログラムの拡大は、市場の成長を促す極めて重要な要因となっています。
市場抑制要因
タイムリーな生産と供給を妨げるサプライチェーンの混乱
サプライチェーンの混乱は、メーカーが人工呼吸器をタイムリーに生産し、ヘルスケア施設に納入することを困難にします。需要の増大とサプライチェーンの混乱は、救命を必要とする患者への救命機器の供給を遅らせる可能性があります。供給不足は機械式人工呼吸器の価格を押し上げ、特に資源に制約のある環境では、ヘルスケア施設にとって購入しにくいものとなります。コストの上昇は医療提供者の予算を圧迫します。場合によっては、サプライチェーンの混乱によって人工呼吸器の調達が急がれ、購入した機器の品質が損なわれる可能性もあります。資源配分の決定は、臨床医にとって精神的な負担となります。サプライチェーンの混乱は、ヘルスケア施設への人工呼吸器輸送の遅れや、効果的な保管・配布の困難さなど、物流上の課題をもたらす可能性があります。したがって、タイムリーな生産と配送を妨げるサプライチェーンの混乱は、市場の成長を鈍化させる可能性があります。
モード別展望
モード別に見ると、市場は侵襲的人工呼吸と非侵襲的人工呼吸に分けられます。2022年には、侵襲的換気分野が市場で最大の収益シェアを記録しました。侵襲的換気は、ICU、手術室、救急部、術後回復など、さまざまな臨床用途で利用されています。この汎用性により、侵襲型人工呼吸器の安定した需要が確保されています。侵襲型人工呼吸器には、患者の安全を確保するための高度なモニタリングシステムとアラームシステムが搭載されています。これには、気道圧、潮容積、酸素濃度などのパラメータの追跡が含まれます。侵襲的人工呼吸は、外傷を負った患者、溺死寸前の患者、その他生命を脅かす緊急事態に陥った患者にとって極めて重要です。このような患者は、早急な挿管と機械的換気を必要とすることがあります。
コンポーネントの展望
コンポーネント別に見ると、市場はデバイスとサービスに二分されます。サービス分野は、2022年の市場で大きな収益シェアを獲得しました。ヘルスケア施設では、機械式人工呼吸器の適切な設置やセットアップのために専門家の支援を必要とすることが多いです。技術サポートとヘルプデスクサービスは、医療従事者が人工呼吸器の問題に遭遇したときにタイムリーな支援を提供します。このサポートにより問題が迅速に解決され、患者ケアの中断が最小限に抑えられます。サービスプロバイダーによっては、遠隔モニタリングおよびトラブルシューティング機能を提供し、離れた場所から人工呼吸器にアクセスして問題を診断できるようにしています。これにより、現場でのサービス接触回数を減らし、問題解決を迅速化することができます。
製品タイプの展望
製品タイプ別では、市場は集中治療室/重症患者用、搬送/携帯/外来用、新生児用に分類されます。2022年には、集中治療室/重症患者ケア分野が市場で最も高い売上シェアを占めました。集中治療室/重症患者ケア分野では、呼吸不全、外傷、感染症、手術の回復など、さまざまな状態に機械式人工呼吸器が使用されます。ICUでは、COPDなどの慢性呼吸器疾患の患者を管理することが多く、急性増悪時に人工呼吸サポートが必要になることがあります。このような慢性的なケアは、集中治療室/クリティカルケア分野の持続的な需要に貢献しています。
年齢層の展望
年齢層別に見ると、市場は成人、老人、小児・新生児に分類されます。2022年の市場では、老年セグメントがかなりの収益シェアを獲得しました。高齢者は、COPD、肺炎、閉塞性睡眠時無呼吸症候群など、加齢に関連した呼吸器疾患にかかりやすいです。高齢者患者は複数の併存疾患を抱えていることが多く、呼吸器疾患を複雑化させ、機械的人工呼吸の必要性を高める可能性があります。一般的な併存疾患には、心臓病、糖尿病、神経障害があります。高齢者の多くは、心臓手術や人工股関節置換術など、様々な病状に対して外科的介入を必要とします。手術後の回復期には高齢患者にとって機械的人工呼吸が必要になることがあり、人工呼吸器の需要に寄与しています。
エンドユーザーの展望
エンドユーザー別では、市場は病院・診療所、外来手術センター、在宅医療、その他に細分化されます。2022年には、病院・診療所セグメントが最も高い収益シェアを獲得して市場をリードしました。病院・診療所セグメントは、慢性呼吸器疾患の患者管理の中心的存在です。機械式人工呼吸器は、神経筋障害や重度の喘息患者に不可欠です。病院やクリニックでは、適切な換気を維持しながら病棟、診療科、医療施設間で患者を安全に移動させるために、搬送用人工呼吸器を使用することが多いです。病院では、患者の自宅まで機械式人工呼吸器の使用を拡大する在宅人工呼吸サービスを提供することがよくあります。これには、ポータブル換気装置の提供や患者とその介護者へのトレーニングが含まれます。
地域別展望
地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が最も高い収益シェアを獲得して市場をリードしました。北米、特に米国とカナダは急速に高齢化が進んでいます。高齢者は呼吸器疾患にかかりやすく、さまざまな病状で人工呼吸が必要になることがあります。北米はCOPDや喘息などの慢性呼吸器疾患の有病率が高いです。機械式人工呼吸器はこれらの疾患、特に増悪時の管理に不可欠です。
The Global Mechanical Ventilators Market size is expected to reach $16.7 billion by 2030, rising at a market growth of 12.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,039.4 thousand units, experiencing a growth of 27.4% (2019-2022).
As per the World Health Organisation, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. Mechanical ventilators are essential for managing these age-related respiratory issues. Consequently, the Geriatric segment captured $2,172.9 million revenue in the market in 2022. It plays a vital role in enhancing the quality of life for older adults by providing advanced respiratory support tailored to their physiological nuances. The elderly population is susceptible to respiratory complications due to weakened respiratory muscles, decreased lung function, and comorbidities.
The major strategies followed by the market participants are Partnerships, Collaborations & Agreements as the key developmental strategy to keep pace with the changing demands of end users. For instance, In June, 2023, Koninklijke Philips N.V. collaborated with Biotronik, aimed to widen the range of cardiovascular devices available for Philips SymphonySuite customers. Additionally, ZOLL Medical Corporation teamed up with Cogmedix, aimed to boost the production of ventilators during the COVID-19 pandemic.
Based on the Analysis presented in the KBV Cardinal matrix; Medtronic PLC is the forerunners in the Market. For Instance, In April, 2022, Medtronic PLC collaborated with GE Healthcare focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Under this collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service. Companies such as General Electric (GE) Co., Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA are some of the key innovators in Market.
COVID-19 Impact Analysis
The most immediate and visible impact of COVID-19 on the market was the unprecedented surge in demand for these life-saving devices. As the virus rapidly spread and overwhelmed healthcare systems in various countries, there was a significant shortage of ventilators to support critically ill patients. Hospitals and healthcare facilities faced an acute need to increase their ventilator capacity to manage the influx of COVID-19 patients. COVID-19 accelerated the adoption of remote monitoring and telehealth solutions, including integrating ventilators into telemedicine networks. These designs focused on essential functions to address the surge in demand, even if they lacked some of the advanced features of traditional ventilators. While these innovations provided short-term relief, they also raised concerns about the quality and safety of rapidly developed devices. Thus, the COVID-19 pandemic had a positive effect on the market.
Market Growth Factors
Rising prevalence of respiratory diseases
Respiratory diseases such as COPD, asthma, and interstitial lung diseases are highly prevalent, particularly in aging populations. These conditions often require long-term or intermittent ventilatory support, creating a sustained demand for mechanical ventilators. Various chronic conditions, such as heart failure and neuromuscular disorders, can result in respiratory complications that require mechanical ventilation for optimal patient care. The co-occurrence of these conditions adds to the demand for ventilators. The prevalence of pediatric and neonatal respiratory disorders, such as respiratory distress syndrome and bronchiolitis, necessitates specialized neonatal and pediatric ventilators. The prevalence of respiratory diseases has driven the integration of mechanical ventilators with telemedicine networks and remote monitoring technologies. This permits healthcare providers to remotely monitor patients with respiratory conditions and adjust ventilator settings, improving access to care. The rising prevalence of respiratory diseases is a significant driver of growth in the market.
Expansion of home ventilation programs
Home ventilation programs create a growing demand for mechanical ventilators in home settings. These ventilators are often more compact, user-friendly, and easy to operate, making them suitable for patients and caregivers. Patients with chronic respiratory conditions, such as COPD, neuromuscular disorders, and obesity hypoventilation syndrome, may require long-term ventilatory support. Home ventilation programs provide a solution for these patients, extending the use of ventilators. Home ventilators are designed with a focus on patient comfort. Telemedicine is frequently integrated into home ventilation programs, allowing patients to access specialist consultations remotely. This is especially important for patients in remote or underserved areas. The expansion of home ventilation programs has been a pivotal factor in driving the growth of the market.
Market Restraining Factors
Supply chain disruptions hampering timely production and delivery
Supply chain disruptions can make it challenging for manufacturers to produce and deliver ventilators to healthcare facilities in a timely manner. Increased demand and supply chain disruptions can delay the provision of life-saving equipment to needy patients. Shortages can drive up the prices of mechanical ventilators, making them less affordable for healthcare facilities, especially in resource-constrained settings. Higher costs can strain the budgets of healthcare providers. In some cases, supply chain disruptions can lead to a rush to procure ventilators, potentially compromising the quality of devices purchased. Decisions about resource allocation can be emotionally taxing for clinicians. The disruption of the supply chain can result in logistical challenges, including delays in transporting ventilators to healthcare facilities and difficulties in storing and distributing them effectively. Thus, supply chain disruptions hampering timely production and delivery can slow down the growth of the market.
Mode Outlook
Based on mode, the market is divided into invasive ventilation and non-invasive ventilation. In 2022, the invasive ventilation segment registered the maximum revenue share in the market. Invasive ventilation is utilized across various clinical applications, including ICUs, operating rooms, emergency departments, and post-operative recovery. This versatility ensures consistent demand for invasive ventilators. Invasive ventilators are equipped with advanced monitoring and alarm systems to ensure patient safety. This includes tracking parameters such as airway pressure, tidal volume, and oxygen levels. Invasive ventilation is crucial for patients who have suffered traumatic injuries, near-drowning incidents, or other life-threatening emergencies. These patients may require immediate intubation and mechanical ventilation.
Component Outlook
On the basis of component, the market is bifurcated into devices and services. The services segment garnered a significant revenue share in the market in 2022. Healthcare facilities often require professional assistance for the proper installation and setup of mechanical ventilators. Technical support and help desk services provide timely assistance to healthcare providers when they encounter issues with ventilators. This support ensures quick problem resolution and minimizes disruptions in patient care. Some service providers offer remote monitoring and troubleshooting capabilities, allowing them to access ventilators and diagnose issues from a distance. This can decrease the number of on-site service contacts and expedite the resolution of issues.
Product Type Outlook
By product type, the market is categorized into intensive care unit/critical care, transport/portable/ambulatory, and neonatal care. In 2022, the intensive care unit/critical care segment held the highest revenue share in the market. The intensive care unit/critical care segment utilizes mechanical ventilators for a wide range of conditions, including respiratory failure, trauma, infections, surgery recovery, and more. ICUs often manage patients with chronic respiratory conditions, such as COPD, who may require ventilatory support during acute exacerbations. This chronic care aspect contributes to sustained demand in the intensive care unit /critical care segment.
Age Group Outlook
Based on age group, the market is classified into adult, geriatric, and pediatric & neonatal. The geriatric segment acquired a substantial revenue share in the market in 2022. Elderly individuals are more prone to age-related respiratory conditions, such as COPD, pneumonia, and obstructive sleep apnea. Geriatric patients often have multiple comorbidities, which can complicate respiratory conditions and lead to a greater need for mechanical ventilation. Common comorbidities include heart disease, diabetes, and neurological disorders. Many elderly individuals require surgical interventions for various medical conditions, such as heart surgery or hip replacement. Post-surgical mechanical ventilation may be necessary for geriatric patients during their recovery, contributing to the demand for ventilators.
End User Outlook
By end user, the market is fragmented into hospital & clinic, ambulatory surgical center, home care, and others. In 2022, the hospital & clinic segment led the market by generating highest revenue share. Hospitals & clinics segment are central in managing patients with chronic respiratory conditions. Mechanical ventilators are essential for patients with neuromuscular disorders or severe asthma. Hospitals & clinics often use transport ventilators to safely transfer patients between units, departments, or healthcare facilities while maintaining proper ventilation. Hospitals often provide home ventilation services, extending the use of mechanical ventilators into patients' homes. This includes the provision of portable ventilators and training for patients and their caregivers.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America, particularly the United States and Canada, has a rapidly aging population. The elderly are more susceptible to respiratory illnesses and may require mechanical ventilation for various medical conditions. North America has a high prevalence of chronic respiratory diseases such as COPD and asthma. Mechanical ventilators are essential for managing these conditions, especially during exacerbations.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Medtronic PLC, Dragerwerk AG & Co. KGaA, Getinge AB, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Carl Reiner GmbH, Mindray Medical International Limited and Vyaire Medical, Inc.
Recent Strategies Deployed in Mechanical Ventilators Market
Partnerships, Collaborations & Agreements:
Oct-2023: Mindray Medical International Limited announced a partnership with Edwards Lifesciences, a global leader in medical innovations. This collaboration made Mindray's BeneVision N-Series the initial patient monitoring system to integrate with Edwards FloTrac sensor for hemodynamic monitoring in the North American market, after their joint launch in China in 2022.
Sep-2023: Medtronic Canada ULC, a subsidiary of Medtronic PLC, partnered with FluidAI Medical, a notable AI startup. Their collaboration aimed to revolutionize Canadian healthcare through the Continuous Connected Patient Care (CCPC) project under Canada's DIGITAL Global Innovation Cluster for digital technologies.
Jul-2023: Mindray Medical International Limited and SingHealth signed a memorandum of understanding aimed at delivering high-quality, accessible patient care. The partnership focused on medical training, academic platform development, and facilitating international exchanges on clinical topics. This collaboration aims to promote knowledge sharing and advance global healthcare.
Jun-2023: Koninklijke Philips N.V. collaborated with Biotronik, a multi-national cardiovascular biomedical research and technology company. This collaboration aimed to widen the range of cardiovascular devices available for Philips SymphonySuite customers.
May-2023: Mindray Medical International Limited signed a strategic agreement with Vithas, a GMP-certified chemical analysis contract lab, allowing Vithas to integrate innovative patient monitoring technology in its 20 hospitals. The partnership aimed to enhance patient safety in critical areas, including the ICU, post-anesthesia recovery, operating rooms, and emergencies.
Apr-2022: Medtronic PLC collaborated with GE Healthcare focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Under this new collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service.
Mar-2022: Asahi Kasei Corporation has teamed up with Genomatica, Inc., a company specializing in biological manufacturing processes for chemicals. Their collaboration is focused on bringing renewable nylon 6,61, created from Genomatica's bio-based HMD building block, to market. This partnership also aligns with Asahi Kasei's goal to be a pioneer in offering eco-friendly nylon 6,6 for the automotive and electronics sectors using plant-based HMD, thereby advancing their sustainability objectives.
Jan-2021: Drager Distribution extended its agreement with Breas Medical. Through this agreement, the companies aimed to supply LTACs and SNFspproch with comprehensive ventilation solutions, cost-effective, designed to improve patient health.
Nov-2020: ZOLL Medical Corporation, a medical devices manufacturer and a member of Asahi Kasei Corporation, teamed up with Cogmedix, provides FDA and ISO 13485 compliant product development and commercialization services. The companies aimed to boost the production of ventilators during the COVID-19 pandemic.
Jun-2020: Medtronic PLC formed a partnership with Foxconn, a multinational electronics contract manufacturer. The companies aimed to enlarge ventilator supply for more patients and hospitals than any other company can do individually.
May-2020: Vyaire Medical collaborated with Spirit AeroSystems, the world's largest manufacturers of aerostructures. Together, the companies aimed to construct critical care ventilators at a transformed space in Wichita, Kan. Moreover, this partnership would permit Vyaire to ramp up rapidly in the production of critical care ventilators.
Apr-2020: GE Healthcare teamed up with Microsoft, an American multinational technology corporation. Together, the companies aimed to launch a new software solution, Mural Virtual Care Solution. This software would give a wide view of the crowd around their ventilated patient and the risk of deterioration.
Apr-2020: Philips formed a partnership with Flex as well as Jabil. The partnership aimed to fast-track the production of ventilators and boost overall supply.
Apr-2020: Royal Philips collaborated with the U.S. Government. The entities aimed to enlarge the production of hospital ventilators, manufacturing in the U.S to save lives all around.
Apr-2020: Vyaire Medical came into a contract of $407 million with Health and Human Services. The companies aimed to construct 22,000 ventilators in the coronavirus pandemic. The entities aimed to increase the production and ramp up the delivery of essential medical equipment required.
Apr-2020: Vyaire Medical received a contract of USD $50 million with the Brazilian Ministry of Health. The companies aimed to construct 4,300 iX5 ventilators during the pandemic. The entities aimed to ramp up manufacturing capacity across the globe to ensure a sufficient supply of ventilators and associated consumables at this crucial time.
Mar-2020: GE Healthcare joined hands with Ford Motor Company, an American multinational automobile manufacturer. The companies focused on growing up the production of ventilators and medical equipment to cure COVID-19 respiratory illness patients.
Mar-2020: Dragerwerk formed a partnership with Babock, international aerospace, defense, and Security Company. This partnership aimed to help in the development of ventilators for the ITV News and NHS.
Product Launches and Expansions:
Jan-2023: Getinge AB launched the Servo-C mechanical ventilator, offering lung-protective tools for pediatric and adult patients in selected markets. With modular components for smart fleet management, the launch aimed to enhance global healthcare accessibility and affordability. Features included CO2 monitoring and a servo compass for visualizing volume and pressure targets.
Mar-2022: ZOLL Medical Corporation, a subsidiary of Asahi Kasei, introduced the ZOLL Arrhythmia Management System (AMS). The system incorporated biometric data with traditional MCT devices, enhancing ECG information. A recent study affirmed that ZOLL AMS assists physicians in creating more informed patient treatment plans.
Oct-2021: Drager introduced the new Savina 300 NIV. This product aimed for consistent and secure non-invasive mechanical ventilation in both acute and chronic care facilities.
Jul-2021: Mindray Medical International Limited launched its new turbine-based ventilator, the SV300 Pro. The product is easy to configure, simple to operate, and flexible in use. Moreover, it provides a comfortable and overall cure for all types of patients with different ventilation modes.
Jun-2020: Royal Philips introduced its mobile Intensive Care Units for India. The product would support the critical-care requirements of patients. Moreover, each pre-fabricated ICU has a space of nine beds which will be produced by Philips in India.
Mergers & Acquisition:
Apr-2021: Dragerwerk took over most of the share from STIMIT, a MedTech company that reinvents intensive care by empowering patients to breathe. This technology aimed to increase the company's expertise in the field of lung-protective ventilation.
Geographical Expansions:
Jan-2022: Getinge expanded its geographical footprints in Wayne, New Jersey by establishing a new Experience Center. The company aimed to utilize healthcare leaders with immense experience and their technologies. In addition to displaying how solutions enlarge efficiencies and amplify the patient experience.
May-2020: Hamilton Medical expanded its global reach in critical care ventilators near the U.S. offices in Reno, Nevada. Through this expansion, the company aimed to supply new production facilities and more life-saving machines to the U.S.
Trials & Approvals:
Jul-2023: Getinge AB obtained US FDA clearance for Servo-air Lite, a wall gas-independent non-invasive mechanical ventilator. This expanded the company's market reach in the US, enabling it to target the non-invasive hospital segment with its ventilation offering.
Market Segments covered in the Report:
By Mode (Volume, Thousand Unit, USD Billion, 2019-30)
By Component (Volume, Thousand Unit, USD Billion, 2019-30)
By Product Type (Volume, Thousand Unit, USD Billion, 2019-30)
By Age Group (Volume, Thousand Unit, USD Billion, 2019-30)
By End User (Volume, Thousand Unit, USD Billion, 2019-30)
By Geography (Volume, Thousand Unit, USD Billion, 2019-30)
Companies Profiled
Unique Offerings from KBV Research